Impact of Diabetes on Long-Term Prognosis in Patients With Unstable Angina and Non–Q-Wave Myocardial Infarction: Results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Circulation

• Publication date

  2000-08-29

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.CIR.102.9.1014PMID 10961966
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mortality and morbidity during a five-year follow-up of diabetics with myocardial infarction.

  2009cited by this paper
• MORTALITY FROM CORONARY HEART DISEASE IN SUBJECTS WITH TYPE 2 DIABETES AND IN NONDIABETIC SUBJECTS WITH AND WITHOUT PRIOR MYOCARDIAL INFARCTION

  2000influential reference
• Diabetes and decline in heart disease mortality in US adults.

  1999cited by this paper
• Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation. OASIS (Organisation to Assess Strategies for Ischaemic Syndromes) Registry Investigators.

  1998cited by this paper
• Metabolic disturbances in diabetic cardiomyopathy

  1998cited by this paper
• Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation

  1998cited by this paper
• Predictors of death during 5 years after hospital discharge among patients with a suspected acute coronary syndrome with particular emphasis on whether an infarction was developed.

  1998cited by this paper
• Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections

  1998cited by this paper
• One-year outcomes of diabetic versus nondiabetic patients with non-Q-wave acute myocardial infarction treated with percutaneous transluminal coronary angioplasty.

  1998cited by this paper
• Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.

  1998cited by this paper
• Outcome of Unstable Angina in Patients with Diabetes Mellitus

  1997cited by this paper
• Mechanisms Determining Course and Outcome of Diabetic Patients Who Have Had Acute Myocardial Infarction

  1997cited by this paper
• Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience.

  1996cited by this paper
• Risk stratification in unstable angina. Prospective validation of the Braunwald classification.

  1995cited by this paper
• Thrombolysis in patients with diabetes

  1995cited by this paper
• Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group.

  1993cited by this paper
• Significance of diabetes mellitus in patients with acute myocardial infarction receiving thrombolytic therapy. Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.

  1993cited by this paper
• Significance of diabetes mellitus in patients with acute myocardial infraction receiving thrombolytic theraphy

  1993cited by this paper
• The diabetic heart: metabolic causes for the development of a cardiomyopathy.

  1992cited by this paper
• Prognostic significance of a predischarge exercise test in risk stratification after unstable angina pectoris.

  1991cited by this paper
• The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. The MILIS Study Group.

  1989cited by this paper
• Myocardial infarction in patients with diabetes mellitus.

  1988cited by this paper
• The impact of diabetes on survival following myocardial infarction in men vs women. The Framingham Study.

  1988cited by this paper

• Metabolic and Mitochondrial Dysregulations in Diabetic Cardiac Complications

  2025influential citation
• Correlation of Glycemic Status with Angiographic Severity of Coronary Artery Disease in Acute Coronary Syndrome.

  2025cites this paper
• Diabetes mellitus and peripheral artery disease

  2025cites this paper
• Impact of lipoprotein (a) on coronary atherosclerosis and plaque progression in patients with type 2 diabetes mellitus

  2025cites this paper
• A Saudi Heart Association Position Statement on Cardiovascular Diseases and Diabetes Mellitus

  2024cites this paper
• Type 2 diabetes mellitus in acute myocardial infarction: a persistent significant burden on long-term mortality

  2024cites this paper
• Effect of different hypoglycemic drugs and insulin on the risk of new-onset atrial fibrillation in people with diabetes: a network meta-analysis

  2024cites this paper
• Insulin Treatment Does Not Prevent EARLY Autonomic Cardiovascular and Diastolic Dysfunctions in Streptozotocin-Induced Diabetic Rats

  2024cites this paper
• Prognostic implications of systemic immune-inflammation index in myocardial infarction patients with and without diabetes: insights from the NOAFCAMI-SH registry

  2024cites this paper
• Early coronary revascularization among ‘stable’ patients with non-ST-segment elevation acute coronary syndromes: the role of diabetes and age

  2024cites this paper
• Diabetes mellitus and presentation, care and outcomes of patients with NSTEMI: the Association for Acute Cardiovascular Care-European Association of Percutaneous Cardiovascular Interventions EURObservational Research Programme NSTEMI Registry of the European Society of Cardiology.

  2024cites this paper
• Association of type 2 diabetes with coronary risk factors, clinical presentation, angiography, coronary interventions and follow-up outcomes: A single centre prospective registry.

  2023cites this paper
• Long-term quality-of-care score for predicting the occurrence of acute myocardial infarction in patients with type 2 diabetes mellitus

  2023cites this paper
• Evolocumab attenuate pericoronary adipose tissue density via reduction of lipoprotein(a) in type 2 diabetes mellitus: a serial follow-up CCTA study

  2023cites this paper
• A trend analysis of Black American women with cardiovascular disease and chronic medical conditions, sociodemographic factors from NHANES From 2011 to 2020

  2023cites this paper
• Lipid goal attainment in diabetes mellitus patients after acute coronary syndrome: a subanalysis of Dyslipidemia International Study II-China

  2023cites this paper
• A bibliometric analysis of acute myocardial infarction in women from 2000 to 2022

  2023cites this paper
• 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes.

  2023cites this paper
• A STUDY ON THE CORRELATION OF ADMISSION HBA1c AND EJECTION FRACTION AMONG NON-DIABETIC UNSTABLE ANGINA PATIENTS

  2023cites this paper
• The many faces of diabetes. Is there a need for re-classification? A narrative review

  2022cites this paper
• Epidemiological‐clinical and paraclinical particularities of acute coronary syndrome without persistent ST‐segment elevation in type 2 diabetes mellitus: Retrospective comparative study in a Malagasy population

  2022cites this paper
• Acute coronary syndromes in diabetic patients, outcome, revascularization, and antithrombotic therapy.

  2022cites this paper
• Association of wound, ischemia, and foot infection clinical stage with frailty and malnutrition in chronic limb-threatening ischemia patients undergoing endovascular intervention

  2022cites this paper
• A Review of the Role of the Antiplatelet Drug Ticagrelor in the Management of Acute Coronary Syndrome, Acute Thrombotic Disease, and Other Diseases

  2022cites this paper
• Modifiers of the Risk of Diabetes for Long-Term Outcomes After Coronary Revascularization

  2022cites this paper
• Endoplasmic Reticulum Stress and Pathogenesis of Vascular Calcification

  2022cites this paper
• Cost-Utility of Prasugrel in Postangioplasty Diabetic Patients.

  2022cites this paper
• Diabetic dyslipidaemia

  2021cites this paper
• Predisposing Risk Factors Associated with Acute Myocardial Infarction (AMI): A Review

  2021cites this paper
• Lipids and lipid‐modifying therapy

  2021cites this paper
• The Effect of HbA1c Level on Gender-Specific Long-Term Morbidity and Mortality After Isolated Coronary Bypass in Poorly Controlled Diabetic Patients

  2021cites this paper
• Association of dipeptidyl peptidase IV polymorphism, serum lipid profile, and coronary artery stenosis in patients with coronary artery disease and type 2 diabetes

  2021influential citation
• Acute Kidney Injury Following Admission with Acute Coronary Syndrome: The Role of Diabetes Mellitus

  2021cites this paper
• Angiographic profile of coronary artery disease in patients with acute coronary syndrome in correlation to their glycaemic status

  2021cites this paper
• Association of the rs17574 DPP4 Polymorphism with Premature Coronary Artery Disease in Diabetic Patients: Results from the Cohort of the GEA Mexican Study

  2021cites this paper
• Clinical and Pharmacological Parameters Determine Relapse During Clopidogrel Treatment of Acute Coronary Syndrome

  2021cites this paper
• Impact of glycosylated haemoglobin (HbA1c) levels on outcomes in patients with myocardial infarction

  2021influential citation
• Diabete e cardiopatia ischemica

  2021cites this paper
• Impact of diabetes in patients waiting for invasive cardiac procedures during COVID-19 pandemic

  2021cites this paper
• Association of tooth loss with morbidity and mortality by diabetes status in older adults: a systematic review

  2021cites this paper
• Diabetes Mellitus and Lower Extremity Peripheral Artery Disease

  2021cites this paper
• A Global Overview of Acute Coronary Syndrome Registries: A Systematic Review.

  2021cites this paper
• Decision models in type 2 diabetes mellitus: A systematic review

  2021cites this paper
• Clinical Outcome between Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndrome and Diabetes

  2021cites this paper
• Prognostic impact of admission high-sensitivity C-reactive protein in acute myocardial infarction patients with and without diabetes mellitus

  2020cites this paper
• Myocardial Infraction: Etiology, Risk Factors, Pathophysiology, Diagnosis and Management

  2020cites this paper
• Assessing risk of future cardiovascular events, healthcare resource utilization and costs in patients with type 2 diabetes, prior cardiovascular disease and both

  2020cites this paper
• ImpaCt of aspirin regimen on THrombin generation in diabEtic patients with acute coronary syndrome: CARTHaGE-ACS trial

  2020cites this paper
• The Effect of Diabetes on Prognosis Following Myocardial Infarction Treated with Primary Angioplasty and Potent Antiplatelet Therapy

  2020cites this paper
• Type 2 Diabetes Mellitus and Impact of Heart Failure on Prognosis Compared to Other Cardiovascular Diseases

  2020cites this paper
• High cardiovascular risk of patients with type 2 diabetes is only partially attributed to angiographic burden of atherosclerosis

  2020cites this paper
• Serum electrolyte/metabolite abnormalities among patients with acute myocardial infarction: comparison between patients with and without diabetes mellitus

  2020cites this paper
• Cardiac biomarkers and left ventricular systolic function in acute myocardial infarction with ST- segment elevation in diabetes mellitus type 2 patients.

  2020cites this paper
• Therapeutic potential of metformin in normal glucose tolerant persons with metabolic syndrome

  2020cites this paper
• Glycated hemoglobin and subsequent risk of microvascular and macrovascular complications

  2020cites this paper
• Revascularization for Coronary Artery Disease: Principle and Challenges.

  2020cites this paper
• Complications of the Type 2 Diabetes Mellitus

  2020influential citation
• Impact of Diabetes Mellitus on Antithrombotic Management Patterns and Long‐Term Clinical Outcomes in Patients With Acute Coronary Syndrome: Insights From the EPICOR Asia Study

  2020cites this paper
• Association between Cardiac Autonomic Neuropathy and Coronary Artery Lesions in Patients with Type 2 Diabetes

  2020cites this paper
• Empagliflozin's Ameliorating Effect on Plasma Triglycerides: Association with Endothelial Function Recovery in Diabetic Patients with Coronary Artery Disease

  2020cites this paper
• Clopidogrel Resistance in a Murine Model of Diet-Induced Obesity Is Mediated by the Interleukin-1 Receptor and Overcome With DT-678

  2020cites this paper
• When diabetes encounters chronic limb-threatening ischemia: Sweet life with a foot left behind?

  2020cites this paper
• Comparison of Extent and Severity of Coronary Artery Disease in Patients with and without Diabetes Mellitus Presenting with Non ST-Segment Elevation Myocardial Infarction

  2020cites this paper
• Cardiomyopathy in obesity, insulin resistance and diabetes

  2020cites this paper
• A relationship between unrecognized anaemia and the development of type 2 diabetes mellitus in patient with cardiovascular risks

  2020cites this paper
• Outcomes of decreasing versus increasing cardiac troponin in patients admitted with non-ST-segment elevation myocardial infarction: the Atherosclerosis Risk in Communities Surveillance Study.

  2019cites this paper
• Comparison of Bleeding and Major Cardiovascular Event Between Enoxaparin and Fondaparinux in Non St-Elevation Myocardial Infarction with Diabetes Mellitus

  2019cites this paper
• Glycemic Variability Is a Powerful Independent Predictive Factor of Midterm Major Adverse Cardiac Events in Patients With Diabetes With Acute Coronary Syndrome

  2019cites this paper
• Epidemiology of Diabetes Mellitus and Cardiovascular Disease

  2019cites this paper
• The importance of dyslipidaemia in the pathogenesis of cardiovascular disease in people with diabetes

  2019cites this paper
• Long‐term impact of diabetes in patients with ST‐segment elevation myocardial infarction: Insights from the EXAMINATION randomized trial

  2019influential citation
• The Role of Platelets in Diabetes Mellitus

  2019cites this paper
• Association between Dipeptidyl Peptidase-4 Inhibitors and Allergic Rhinitis in Asian Patients with Diabetes

  2019cites this paper
• DMSO_A_188680 1597..1615

  2019cites this paper
• Diabetic Cardiomyopathy Pathophysiology and Update on Treatment

  2019cites this paper
• Coronary risk equivalence of diabetes assessed by SPECT-MPI

  2019cites this paper
• Prediction of major adverse cardiac, cerebrovascular events in patients with diabetes after acute coronary syndrome

  2019cites this paper
• Interaction Between Diabetes Mellitus and Platelet Reactivity in Determining Long-Term Outcomes Following Percutaneous Coronary Intervention

  2019influential citation
• Empagliflozin Ameliorating Effect of on Plasma Triglyceride: An Association with Endothelial Function Recovery in Diabetic Patients with Coronary Artery Disease

  2019cites this paper
• Regulation of alternative splicing in obesity-induced hypertension

  2019cites this paper
• Das "Reduction of Atherothrombosis for Continued Health-(REACH-) Register": Basisdaten der österreichischen Population

  2019cites this paper
• Reasons for admission of individual with diabetes to the Tripoli Medical Center in 2015.

  2019cites this paper
• 2 Type 2 Diabetes

  2019cites this paper
• Extreme Atherosclerotic Cardiovascular Disease (ASCVD) Risk Recognition

  2019cites this paper
• Plaque characteristics of culprit lesions in patients with unstable angina with and without diabetes and their relationship with outcomes of PCI: IVUS analysis

  2019cites this paper
• Flow-mediated dilatation Empagliflozin ’ s Ameliorating Effect on Plasma Triglycerides : Association with Endothelial Function Recovery in Diabetic Patients with Coronary Artery Disease

  2019cites this paper
• Clinical significance of diabetes on symptom and patient delay among patients with acute myocardial infarction—an analysis from China Acute Myocardial Infarction (CAMI) registry

  2019cites this paper
• INHIBIDORES DE ENZIMA CONVERTIDORA DE ANGIOTENSINA DISMINUYENDO RIESGO DE INFARTO AGUDO DE MIOCARDIO EN DIABÉTICOS

  2019cites this paper
• Glucose-lowering therapy and cardiovascular outcomes in patients with type 2 diabetes mellitus and acute coronary syndrome

  2019cites this paper
• Outcomes of decreasing versus increasing cardiac troponin in patients admitted with non-ST-segment elevation myocardial infarction: the Atherosclerosis Risk in Communities Surveillance Study.

  2019cites this paper
• STUDY OF BASELINE CHARACTERISTICS AND 1-YEAR FOLLOW-UP OF DIABETIC AND NON-DIABETIC PATIENTS OF STEMI

  2018cites this paper
• CYP2C19 or CYP3A5 Genotyping Does Not Predict Clinical Response to Clopidogrel

  2018cites this paper
• Aalborg Universitet European Heart Rhythm Association ( EHRA ) position paper on arrhythmia management and device therapies in endocrine disorders , endorsed by Asia Pacific Heart Rhythm Society ( APHRS ) and Latin American Heart Rhythm Society ( LAHRS )

  2018cites this paper
• Chapter 43 – Diabetes and Cardiovascular Disease

  2018cites this paper
• Management of Acute Coronary Syndromes Diabetes Canada Clinical Practice Guidelines Expert Committee

  2018cites this paper
• Utilization of Statins in Reducing Comorbidities of Diabetes Mellitus: A Systematic Review

  2018cites this paper
• Effect of pioglitazone on cardiometabolic profiles and safety in patients with type 2 diabetes undergoing percutaneous coronary artery intervention: a prospective, multicenter, randomized trial

  2018cites this paper
• Configuration of dyslipidemia in patients with type 2 diabetes mellitus visiting tertiary care hospital Quetta-Pakistan

  2018cites this paper
• A Novel Risk Scoring System to Predict Cardiovascular Death in Patients With Acute Myocardial Infarction: CHA2DS2-VASc-CF Score

  2018cites this paper
• Comparative Outcome of Acute Coronary Syndrome In Diabetics and Non-diabetics

  2018cites this paper